The stock of Akers Biosciences, Inc. (NASDAQ:AKER) is now priced at $5.25 and the shares are -0.66 points down or -11.17% lower compared to its previous closing price of $5.91. The stock had 2.609 million contracts set over the past session. AKER shares’ daily volume is compared to its average trading volume at 1.052 million shares. However, it has a float of 8.3 million and although its performance was -13.37% over the week, it’s one to watch. It means the stock’s downside potential is -100% with the AKER share price recently placing at $4.69 to $5.89. However, some brokerage firms have priced the stock below the average, including one that has called $768.
The shorts are climbing into the Akers Biosciences, Inc. stock, with the latest data on short interest released on July 31, 2020, showing that short interest numbers in the AKER shares have risen. Short interest in the stock represents just 2.24% of its float, but the volume has raised by 76541. The volume of shorted shares rised to 185704 from 109163 shares over the last two weeks. The average intraday trading volume has been 1.371 million shares, which means that days to cover moved to roughly 1.
In the last trading session, Akers Biosciences, Inc. (NASDAQ:AKER) dropped by -$0.81 over the week and gained $0.31 on its 20-day. The stock’s high in the recent session is lower when compared to its 52-week high of $12.72. The stock recorded its established 52-week high on 09/16/19.
Since 03/16/20, the stock has traded to a low of $1.55 at 238.71%, an encouraging piece of data likely to interest most investors out to exploit the stock’s recent surge. The stock has a beta allocation of 0.43. Being above 1 means that the stock’s volatility is higher than the market and traders are keenly watching it.
Looking at current readings, Akers Biosciences, Inc.’s two-week RSI is 48.49. This suggests that the stock is neutral at the moment and that AKER shares’ price movement remains stable. The stochastic readings are equally revealing at 47.41% meaning the AKER share price is currently in neutral territory.
The technical chart shows that the AKER stock will likely settle at between $5.86 and $6.48 per share. However, if the stock dips below $4.66, then its market would become much weaker. Any downside could see the stock price sliding to levels as low as $4.08.
Currently, the stock is trading in the red of MACD, with a reading of -0.05. Investors always pay attention to any move above or below the zero-line, mainly because the indicator points to the position of the stock’s short-term average relative to its long-term measure. A MACD -a reading above the zero line means that the short-term is above the long-term average. This scenario implies that there is an upward momentum. The opposite is true when the MACD falls below the zero-line.
The stocks P/S ratio currently stands below the group’s average of 81.8. Akers Biosciences, Inc. has its P/E ratio at 2.9, which means that the stock is currently trading at a discount relative to the 4.5 industry average.